studied pharmacy at the University of Erlangen, Germany and received his PhD degree in Pharmaceutical Technology.
After eight years with Bayer’s pharmaceutical development and clinical supplies team in Leverkusen he joined Glatt in 1995. Until 2020, he was responsible for Glatt Pharmaceutical Services GmbH & Co.KG in Binzen, Glatt’s CDMO organisation in Germany. His activities focused on pharmaceutical development and manufacturing services as well as new technologies. Retired in 2021, he is now active as a senior consultant.
His area of expertise is oral dosage forms. One focus is placed on multiparticulate applications, such as pellets and micropellets. Another focus is the optimisation of API solubility and bioavailability using different technology platforms such as amorphous solid dispersions (ASD) and solubiliser-based solid dispersions and self-emulsifying systems.